SoylentNews is people
SoylentNews
Arthur T Knackerbracket has found the following story:
A new study led by an infectious disease epidemiologist at Tulane University School of Public Health and Tropical Medicine could change the way doctors treat a common sexually transmitted disease.
Professor Patricia Kissinger and a team of researchers found the recommended single dose of medication isn't enough to eliminate trichomoniasis, the most common curable STD, which can cause serious birth complications and make people more susceptible to HIV. Results of the research are published in Lancet Infectious Diseases.
Globally, an estimated 143 million new cases of trichomoniasis among women occur each year and most do not have symptoms, yet the infection is causing unseen problems. The recommended treatment for more than three decades has been a single dose of the antibiotics metronidazole or tinidazole.
The researchers recruited more than 600 women for the randomized trial in New Orleans; Jackson, Mississippi; and Birmingham, Alabama. Half the women took a single dose of metronidazole and the other half received treatment over seven days.
Kissinger and her team found the women who received multiple doses of the treatment were half as likely to still have the infection after taking all the medication compared to women who only took a single dose.
-- submitted from IRC
Patricia Kissinger, et. al. Single-dose versus 7-day-dose metronidazole for the treatment of trichomoniasis in women: an open-label, randomised controlled trial. The Lancet Infectious Diseases, 2018; DOI: 10.1016/S1473-3099(18)30423-7
(Score: 1, Interesting) by Anonymous Coward on Wednesday October 10 2018, @01:09PM
This study indirectly sponsored by Aurobindo Pharma Ltd, the manufacturer of metronidazole! Remember kids, one dose is not enough, buy two or three! It's the only way to be sure! /s